AU2006327761A1 - Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria - Google Patents
Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria Download PDFInfo
- Publication number
- AU2006327761A1 AU2006327761A1 AU2006327761A AU2006327761A AU2006327761A1 AU 2006327761 A1 AU2006327761 A1 AU 2006327761A1 AU 2006327761 A AU2006327761 A AU 2006327761A AU 2006327761 A AU2006327761 A AU 2006327761A AU 2006327761 A1 AU2006327761 A1 AU 2006327761A1
- Authority
- AU
- Australia
- Prior art keywords
- gram positive
- bacteria
- mice
- efd
- killed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CC1C*CC1 Chemical compound CC1C*CC1 0.000 description 1
- YXHDJVRBGZGAHX-ZNOXQBFJSA-N C[C@@H](CC1)C1(C)C1(C)CC(C)CC1 Chemical compound C[C@@H](CC1)C1(C)C1(C)CC(C)CC1 YXHDJVRBGZGAHX-ZNOXQBFJSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/32—Mycobacterium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2,531,261 | 2005-12-21 | ||
| CA002531261A CA2531261A1 (en) | 2005-12-21 | 2005-12-21 | Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
| PCT/IB2006/004133 WO2007072230A2 (en) | 2005-12-21 | 2006-12-21 | Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2006327761A1 true AU2006327761A1 (en) | 2007-06-28 |
Family
ID=38175409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006327761A Abandoned AU2006327761A1 (en) | 2005-12-21 | 2006-12-21 | Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090280146A1 (https=) |
| EP (1) | EP1971352A2 (https=) |
| JP (1) | JP2009520810A (https=) |
| KR (1) | KR20080092384A (https=) |
| CN (1) | CN101384270A (https=) |
| AU (1) | AU2006327761A1 (https=) |
| CA (2) | CA2531261A1 (https=) |
| IL (1) | IL192048A0 (https=) |
| MX (1) | MX2008008157A (https=) |
| WO (1) | WO2007072230A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2087898A1 (en) * | 2008-02-06 | 2009-08-12 | Institut Pasteur | A preparation of mycobacterium bovis BCG killed by extended freeze drying (EFD) for treating rheumatoid arthritis |
| CA2629057A1 (en) * | 2008-04-14 | 2009-10-14 | Institut Pasteur | Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria |
| EP2292260A1 (en) | 2009-08-13 | 2011-03-09 | Institut Pasteur | Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis |
| NZ702796A (en) * | 2010-07-26 | 2017-03-31 | Qu Biologics Inc | Immunogenic anti-inflammatory compositions |
| WO2013004069A1 (zh) * | 2011-07-05 | 2013-01-10 | 苏州科景生物医药科技有限公司 | 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用 |
| US9886742B2 (en) | 2016-03-17 | 2018-02-06 | Google Llc | Electro-optic beam steering for super-resolution/lightfield imagery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR012304A1 (es) * | 1997-04-01 | 2000-10-18 | Borody Thomas J | Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos. |
| WO1998047520A1 (en) * | 1997-04-24 | 1998-10-29 | Lovelace Respiratory Research Institute | Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity |
| AUPQ776100A0 (en) * | 2000-05-26 | 2000-06-15 | Australian National University, The | Synthetic molecules and uses therefor |
| GB0106987D0 (en) * | 2001-03-20 | 2001-05-09 | Stanford Rook Ltd | Immunotherapeuitic agent |
| EP2316466B1 (en) * | 2001-12-11 | 2013-08-21 | Institut Pasteur | Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| JP2005531289A (ja) * | 2002-02-15 | 2005-10-20 | アゲルプ ファーマ ゲーエムベーハー | S.aureusエンテロトキシンB由来の免疫調節ペプチド |
-
2005
- 2005-12-21 CA CA002531261A patent/CA2531261A1/en not_active Abandoned
-
2006
- 2006-12-21 CN CNA2006800532346A patent/CN101384270A/zh active Pending
- 2006-12-21 KR KR1020087017840A patent/KR20080092384A/ko not_active Withdrawn
- 2006-12-21 WO PCT/IB2006/004133 patent/WO2007072230A2/en not_active Ceased
- 2006-12-21 AU AU2006327761A patent/AU2006327761A1/en not_active Abandoned
- 2006-12-21 JP JP2008546689A patent/JP2009520810A/ja not_active Withdrawn
- 2006-12-21 EP EP06848694A patent/EP1971352A2/en not_active Withdrawn
- 2006-12-21 MX MX2008008157A patent/MX2008008157A/es not_active Application Discontinuation
- 2006-12-21 CA CA002632839A patent/CA2632839A1/en not_active Abandoned
- 2006-12-21 US US12/158,827 patent/US20090280146A1/en not_active Abandoned
-
2008
- 2008-06-10 IL IL192048A patent/IL192048A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101384270A (zh) | 2009-03-11 |
| IL192048A0 (en) | 2009-02-11 |
| WO2007072230A3 (en) | 2007-11-22 |
| CA2632839A1 (en) | 2007-06-28 |
| WO2007072230A2 (en) | 2007-06-28 |
| KR20080092384A (ko) | 2008-10-15 |
| EP1971352A2 (en) | 2008-09-24 |
| MX2008008157A (es) | 2008-09-24 |
| JP2009520810A (ja) | 2009-05-28 |
| CA2531261A1 (en) | 2007-06-21 |
| US20090280146A1 (en) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220257668A1 (en) | Compositions comprising bacterial strains | |
| JP7497433B2 (ja) | ラクトバチルス・パラカゼイk56の腸管炎症の緩和における新規な用途 | |
| EP3204024B1 (en) | Compositions comprising bacterial strains | |
| US20220401499A1 (en) | New use of bifidobacterium lactis bl-99 in suppression of intestinal inflammation | |
| US20120082699A1 (en) | Method of Producing Rough Strains of Bacteria and Uses Thereof | |
| CN101138573A (zh) | 酪酸梭菌、凝结芽孢杆菌制备治疗炎症性肠病药物中的应用 | |
| NZ533422A (en) | Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation | |
| AU2006327761A1 (en) | Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria | |
| FI120136B (fi) | Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi | |
| CA2571886A1 (en) | Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria | |
| CN114908023B (zh) | 一株提高肠道放线菌门相对丰度、抑制促炎症因子表达量的凝结芽孢杆菌 | |
| JP2004262773A (ja) | 免疫機能改善を目的としたビフィズス菌製剤 | |
| JP2024546437A (ja) | 疾患を処置するための細菌株 | |
| CN116942685B (zh) | 酸性羊乳寡糖组合物在制备抗过敏药物或食物中的应用 | |
| JP2025518621A (ja) | アルツハイマー病および老化の治療および予防のためのラクノスピラ科菌種およびルミノコッカス・ラクタリス菌株 | |
| US20040247622A1 (en) | Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae | |
| Adilbekova | PROBIOTICS AS ADDITIONAL TREATMENT OF RHEUMATOID ARTHRITIS. A REVIEW. | |
| IBRAEVA et al. | SCIENCE & HEALTHCARE | |
| Händel et al. | P297-Local fuelling of IL-2 determines the tissue localisation of CD4+ Foxp3+ regulatory T cells–proliferating cells signal inflammation and provide IL-2 | |
| HK1240831A1 (en) | Compositions comprising bacterial strains | |
| HK1240831B (en) | Compositions comprising bacterial strains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |